1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. IDEX Biometrics ASA
  6. Financials
    IDEX   NO0003070609

IDEX BIOMETRICS ASA

(IDEX)
  Report
Real-time Oslo Bors  -  05/25 09:15:09 am EDT
1.186 NOK   -3.26%
05/23IDEX BIOMETRICS : Subscription Rights Exercise – 23 May 2022
GL
05/23IDEX BIOMETRICS : Subscription Rights Exercise – 23 May 2022
AQ
05/13European ADRs Move Higher in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 9192 4803 1931 241--
Enterprise Value (EV)1 9192 4803 1931 2411 2411 241
P/E ratio -2,67x-11,8x----
Yield ------
Capitalization / Revenue 247x269x128x17,7x3,04x1,27x
EV / Revenue 247x269x128x17,7x3,04x1,27x
EV / EBITDA --11,7x-12,2x-4,98x-10,1x47,8x
Price to Book ------
Nbr of stocks (in thousands) 717 989832 1471 010 3881 012 609--
Reference price (NOK) 1,282,983,161,231,231,23
Announcement Date 02/27/202002/25/202102/24/2022---
1 NOK in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 3,729,2324,970,3408974
EBITDA1 --213-262-249-12226,0
Operating profit (EBIT)1 --214-279-293-15510,6
Operating Margin --2 320%-1 120%-417%-37,9%1,09%
Pre-Tax Profit (EBT)1 --226-288-294-1551,76
Net income1 --226-289-295-1551,76
Net margin --2 443%-1 163%-419%-38,0%0,18%
EPS -0,48-0,25----
Dividend per Share ------
Announcement Date 02/27/202002/25/202102/24/2022---
1 NOK in Million
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 6,246,999,5711,714,734,2
EBITDA1 -59,7--73,9-64,3-63,7-53,6
Operating profit (EBIT)1 -63,6-80,2-77,4-75,3-74,7-64,6
Operating Margin -1 019%-1 147%-809%-642%-510%-189%
Pre-Tax Profit (EBT)1 -63,7-90,9-78,6-75,3-74,7-64,6
Net income1 -63,7-91,7-78,6-75,6-75,0-64,9
Net margin -1 020%-1 311%-821%-644%-511%-190%
EPS ---0,10---
Dividend per Share ------
Announcement Date 11/04/202102/24/202205/12/2022---
1 NOK in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow --197----
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Announcement Date 02/27/202002/25/202102/24/2022---
1 NOK in Million
Previous periodNext period
Estimates
Key data
Capitalization (NOK) 1 241 458 700
Capitalization (USD) 129 410 280
Net sales (NOK) 24 874 440
Net sales (USD) 2 592 924
Number of employees 108
Sales / Employee (NOK) 230 319
Sales / Employee (USD) 24 009
Free-Float 74,0%
Free-Float capitalization (NOK) 918 498 285
Free-Float capitalization (USD) 95 744 724
Avg. Exchange 20 sessions (NOK) 10 454 679
Avg. Exchange 20 sessions (USD) 1 089 801
Average Daily Capital Traded 0,84%
EPS & Dividend